Treatment of NSCLC after chemoimmunotherapy — are we making headway?

Martin Reck, Nikolaj Frost, Solange Peters, Bernard A. Fox, Roberto Ferrara, Rajkumar Savai, Fabrice Barlesi

Open source

DOI
10.1038/s41571-025-01061-7
Published
2025-08-14
Container
Nature Reviews Clinical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41571-025-01061-7,
  title = {Treatment of NSCLC after chemoimmunotherapy — are we making headway?},
  author = {Martin Reck and Nikolaj Frost and Solange Peters and Bernard A. Fox and Roberto Ferrara and Rajkumar Savai and Fabrice Barlesi},
  year = {2025},
  journal = {Nature Reviews Clinical Oncology},
  doi = {10.1038/s41571-025-01061-7},
  url = {https://doi.org/10.1038/s41571-025-01061-7}
}

RIS

TY  - JOUR
TI  - Treatment of NSCLC after chemoimmunotherapy — are we making headway?
AU  - Martin Reck
AU  - Nikolaj Frost
AU  - Solange Peters
AU  - Bernard A. Fox
AU  - Roberto Ferrara
AU  - Rajkumar Savai
AU  - Fabrice Barlesi
PY  - 2025
JO  - Nature Reviews Clinical Oncology
DO  - 10.1038/s41571-025-01061-7
UR  - https://doi.org/10.1038/s41571-025-01061-7
ER  - 

APA

Reck, M., Frost, N., Peters, S., Fox, B. A., Ferrara, R., Savai, R., & Barlesi, F. (2025). Treatment of NSCLC after chemoimmunotherapy — are we making headway?. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-025-01061-7

Source records